DFISX | GICCX | DFISX / GICCX | |
Total Expense Ratio | 0.39 | 1.97 | 20% |
Annual Report Gross Expense Ratio | 0.39 | 2.02 | 19% |
Fund Existence | 29 years | 18 years | - |
Gain YTD | 26.894 | 30.008 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.8B | 5.44B | 254% |
Annual Yield % from dividends | 3.25 | 2.65 | 123% |
Returns for 1 year | 27.32 | 28.73 | 95% |
Returns for 3 years | 42.53 | 48.17 | 88% |
Returns for 5 years | 55.19 | 57.79 | 95% |
Returns for 10 years | 52.39 | 73.31 | 71% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RFNFX | 90.69 | 1.21 | +1.35% |
American Funds Fundamental Invs R5 | |||
VCRAX | 14.60 | 0.06 | +0.41% |
NYLI CBRE Global Infrastructure Class A | |||
DTEYX | 87.70 | N/A | N/A |
BNY Mellon Technology Growth Y | |||
ARVIX | 12.43 | N/A | N/A |
ARGA International Value Institutional | |||
FBIOX | 19.55 | N/A | N/A |
Fidelity Select Biotechnology |